Inhibrx Biosciences Inc (NASDAQ: INBX) kicked off on Tuesday, up 16.38% from the previous trading day, before settling in for the closing price of $58.85. Over the past 52 weeks, INBX has traded in a range of $10.81-$61.21.
While this was happening, its average annual earnings per share was recorded -107.21%. With a float of $9.86 million, this company’s outstanding shares have now reached $14.48 million.
Inhibrx Biosciences Inc (INBX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Inhibrx Biosciences Inc is 31.91%, while institutional ownership is 56.85%. The most recent insider transaction that took place on Oct 07 ’25, was worth 11,287,500. In this transaction 10% Owner of this company sold 350,000 shares at a rate of $32.25, taking the stock ownership to the 67,018 shares. Before that another transaction happened on Nov 19 ’24, when Company’s Director bought 69,686 for $14.23, making the entire transaction worth $991,416. This insider now owns 51,093 shares in total.
Inhibrx Biosciences Inc (INBX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -2.84 earnings per share (EPS), higher than consensus estimate (set at -3.7) by 0.86. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -107.21% per share during the next fiscal year.
Inhibrx Biosciences Inc (NASDAQ: INBX) Trading Performance Indicators
Take a look at Inhibrx Biosciences Inc’s (INBX) current performance indicators. Last quarter, stock had a quick ratio of 4.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 708.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.99, a number that is poised to hit -1.72 in the next quarter and is forecasted to reach -9.32 in one year’s time.
Technical Analysis of Inhibrx Biosciences Inc (INBX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.99 million. That was better than the volume of 0.16 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 94.56%.
During the past 100 days, Inhibrx Biosciences Inc’s (INBX) raw stochastic average was set at 99.93%, which indicates a significant increase from 99.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.96 in the past 14 days, which was higher than the 1.99 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.18, while its 200-day Moving Average is $19.36. However, in the short run, Inhibrx Biosciences Inc’s stock first resistance to watch stands at $72.07. Second resistance stands at $75.65. The third major resistance level sits at $82.77. If the price goes on to break the first support level at $61.37, it is likely to go to the next support level at $54.25. Assuming the price breaks the second support level, the third support level stands at $50.67.
Inhibrx Biosciences Inc (NASDAQ: INBX) Key Stats
The company with the Market Capitalisation of 992.11 million has total of 14,485K Shares Outstanding. Its annual sales at the moment are 200 K in contrast with the sum of 1,688 M annual income. Company’s last quarter sales were recorded 1,300 K and last quarter income was -28,650 K.
